Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elena Fradkov, M.D.

Concepts (62)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiodysplasia12017220.560 Why?
Nursing Staff120171130.540 Why?
Cannabinoids120191740.530 Why?
Skin Diseases1202210840.440 Why?
Gastroenterology120175930.360 Why?
Colitis1201912380.350 Why?
Gastrointestinal Hemorrhage1201711260.340 Why?
Crohn Disease1202222860.330 Why?
Endoscopy1201718540.290 Why?
Heart-Assist Devices1201712870.270 Why?
Ventricular Function, Left1201739340.230 Why?
Students, Medical1201719620.230 Why?
Leukocyte L1 Antigen Complex12022920.200 Why?
Interleukin-23120222020.180 Why?
Endoscopy, Gastrointestinal120228890.130 Why?
Vomiting120196520.120 Why?
Platelet Aggregation Inhibitors2201727630.120 Why?
Heart Failure12017118790.100 Why?
Syndrome1201932710.100 Why?
Anticoagulants2201748540.100 Why?
Blood Coagulation1201711630.090 Why?
History, 21st Century1201715740.090 Why?
Guidelines as Topic1201713940.090 Why?
Skin Diseases, Vesiculobullous12011820.090 Why?
C-Reactive Protein1202238530.090 Why?
Prosthesis Design1201721200.090 Why?
Teaching1201711710.080 Why?
History, 20th Century1201727640.080 Why?
Warfarin1201714930.080 Why?
Receptor, Adenosine A2B12008340.080 Why?
Receptor, Adenosine A2A120081280.080 Why?
Fibrinolytic Agents1201720780.070 Why?
Guideline Adherence1201722330.070 Why?
Recovery of Function1201729780.070 Why?
Aspirin1201731340.060 Why?
Case-Control Studies12022222480.060 Why?
Treatment Outcome22022652860.050 Why?
Inflammation12022108630.050 Why?
Quality Improvement1201738500.050 Why?
Killer Cells, Natural1201122090.050 Why?
Clinical Competence1201748580.050 Why?
T-Lymphocytes, Cytotoxic1200818020.050 Why?
Immune Tolerance1200823280.040 Why?
Autoimmune Diseases1201122550.040 Why?
Risk Assessment12017242990.030 Why?
Humans520227668120.030 Why?
Retrospective Studies12022816570.030 Why?
Pemphigus120111070.020 Why?
Risk Factors12017748890.020 Why?
Adenosine-5'-(N-ethylcarboxamide)12008160.020 Why?
Adenosine A2 Receptor Agonists12008310.020 Why?
Mice, Inbred DBA120086240.020 Why?
Animals220171689390.020 Why?
Extracellular Space120085630.020 Why?
Cytotoxicity, Immunologic1200813520.010 Why?
Cyclic AMP1200814720.010 Why?
Adenosine120088120.010 Why?
Interferon-gamma1200831570.010 Why?
Lymphocyte Activation1200855020.010 Why?
Cell Line, Tumor12008170890.010 Why?
Mice, Inbred C57BL12008223510.010 Why?
Mice12008818980.000 Why?
Fradkov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (62)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.